Logo image of INLX

INTELLINETICS INC (INLX) Stock Fundamental Analysis

USA - NYSEARCA:INLX - US45825X2045 - Common Stock

11.1 USD
-0.65 (-5.53%)
Last: 10/16/2025, 8:04:01 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to INLX. INLX was compared to 282 industry peers in the Software industry. INLX scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. INLX is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

INLX had negative earnings in the past year.
In the past year INLX had a positive cash flow from operations.
In multiple years INLX reported negative net income over the last 5 years.
Each year in the past 5 years INLX had a positive operating cash flow.
INLX Yearly Net Income VS EBIT VS OCF VS FCFINLX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M

1.2 Ratios

INLX has a worse Return On Assets (-10.15%) than 61.70% of its industry peers.
The Return On Equity of INLX (-15.06%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -10.15%
ROE -15.06%
ROIC N/A
ROA(3y)-0.03%
ROA(5y)-2%
ROE(3y)0.16%
ROE(5y)-27.83%
ROIC(3y)N/A
ROIC(5y)N/A
INLX Yearly ROA, ROE, ROICINLX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200 -400 -600

1.3 Margins

Looking at the Gross Margin, with a value of 65.50%, INLX is in line with its industry, outperforming 44.68% of the companies in the same industry.
In the last couple of years the Gross Margin of INLX has declined.
The Profit Margin and Operating Margin are not available for INLX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 65.5%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.83%
GM growth 5Y-3.79%
INLX Yearly Profit, Operating, Gross MarginsINLX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150

More info and screens

5

2. Health

2.1 Basic Checks

INLX does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for INLX has been increased compared to 1 year ago.
INLX has more shares outstanding than it did 5 years ago.
INLX has a better debt/assets ratio than last year.
INLX Yearly Shares OutstandingINLX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M
INLX Yearly Total Debt VS Total AssetsINLX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

2.2 Solvency

INLX has an Altman-Z score of 4.17. This indicates that INLX is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 4.17, INLX is in the better half of the industry, outperforming 65.60% of the companies in the same industry.
The Debt to FCF ratio of INLX is 0.16, which is an excellent value as it means it would take INLX, only 0.16 years of fcf income to pay off all of its debts.
With an excellent Debt to FCF ratio value of 0.16, INLX belongs to the best of the industry, outperforming 80.85% of the companies in the same industry.
A Debt/Equity ratio of 0.01 indicates that INLX is not too dependend on debt financing.
The Debt to Equity ratio of INLX (0.01) is better than 63.83% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.16
Altman-Z 4.17
ROIC/WACCN/A
WACC11.43%
INLX Yearly LT Debt VS Equity VS FCFINLX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M

2.3 Liquidity

A Current Ratio of 0.98 indicates that INLX may have some problems paying its short term obligations.
INLX has a worse Current ratio (0.98) than 73.76% of its industry peers.
A Quick Ratio of 0.95 indicates that INLX may have some problems paying its short term obligations.
INLX has a worse Quick ratio (0.95) than 73.05% of its industry peers.
Industry RankSector Rank
Current Ratio 0.98
Quick Ratio 0.95
INLX Yearly Current Assets VS Current LiabilitesINLX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M

More info and screens

3

3. Growth

3.1 Past

INLX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -1100.00%.
Looking at the last year, INLX shows a decrease in Revenue. The Revenue has decreased by -2.63% in the last year.
Measured over the past years, INLX shows a very strong growth in Revenue. The Revenue has been growing by 48.02% on average per year.
EPS 1Y (TTM)-1100%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-750%
Revenue 1Y (TTM)-2.63%
Revenue growth 3Y16.28%
Revenue growth 5Y48.02%
Sales Q2Q%-13.59%

3.2 Future

The Earnings Per Share is expected to decrease by -54.27% on average over the next years. This is quite bad
Based on estimates for the next years, INLX will show a small growth in Revenue. The Revenue will grow by 4.13% on average per year.
EPS Next Y-325%
EPS Next 2Y-54.27%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-5.04%
Revenue Next 2Y4.13%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
INLX Yearly Revenue VS EstimatesINLX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 5M 10M 15M
INLX Yearly EPS VS EstimatesINLX Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2020 2021 2022 2023 2024 2025 2026 0 -2 -4 -6

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

INLX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year INLX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
INLX Price Earnings VS Forward Price EarningsINLX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40

4.2 Price Multiples

Compared to the rest of the industry, the Price/Free Cash Flow ratio of INLX indicates a somewhat cheap valuation: INLX is cheaper than 66.31% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 36.81
EV/EBITDA N/A
INLX Per share dataINLX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3

4.3 Compensation for Growth

A cheap valuation may be justified as INLX's earnings are expected to decrease with -54.27% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-54.27%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

INLX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

INTELLINETICS INC

NYSEARCA:INLX (10/16/2025, 8:04:01 PM)

11.1

-0.65 (-5.53%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)08-13 2025-08-13/amc
Earnings (Next)11-11 2025-11-11/amc
Inst Owners7.51%
Inst Owner Change0%
Ins Owners27.64%
Ins Owner Change0.43%
Market Cap49.73M
Analysts82.86
Price Target14.79 (33.24%)
Short Float %0.02%
Short Ratio0.29
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-32.42%
Min EPS beat(2)-85.19%
Max EPS beat(2)20.34%
EPS beat(4)2
Avg EPS beat(4)-239.86%
Min EPS beat(4)-982.35%
Max EPS beat(4)87.75%
EPS beat(8)3
Avg EPS beat(8)-157.68%
EPS beat(12)6
Avg EPS beat(12)-29.95%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-7.01%
Min Revenue beat(2)-7.48%
Max Revenue beat(2)-6.54%
Revenue beat(4)0
Avg Revenue beat(4)-4.52%
Min Revenue beat(4)-7.48%
Max Revenue beat(4)-0.09%
Revenue beat(8)2
Avg Revenue beat(8)-2.24%
Revenue beat(12)5
Avg Revenue beat(12)-0.29%
Revenue beat(16)8
Avg Revenue beat(16)0.13%
PT rev (1m)0%
PT rev (3m)-12.12%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)-31.58%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-10.2%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-10.37%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.9
P/FCF 36.81
P/OCF 22.08
P/B 4.3
P/tB 25.37
EV/EBITDA N/A
EPS(TTM)-0.4
EYN/A
EPS(NY)-0.29
Fwd EYN/A
FCF(TTM)0.3
FCFY2.72%
OCF(TTM)0.5
OCFY4.53%
SpS3.82
BVpS2.58
TBVpS0.44
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -10.15%
ROE -15.06%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 65.5%
FCFM 7.89%
ROA(3y)-0.03%
ROA(5y)-2%
ROE(3y)0.16%
ROE(5y)-27.83%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.83%
GM growth 5Y-3.79%
F-Score5
Asset Turnover1
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.16
Debt/EBITDA N/A
Cap/Depr 68.63%
Cap/Sales 5.26%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.98
Quick Ratio 0.95
Altman-Z 4.17
F-Score5
WACC11.43%
ROIC/WACCN/A
Cap/Depr(3y)67.37%
Cap/Depr(5y)74.13%
Cap/Sales(3y)3.99%
Cap/Sales(5y)3.61%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1100%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-750%
EPS Next Y-325%
EPS Next 2Y-54.27%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-2.63%
Revenue growth 3Y16.28%
Revenue growth 5Y48.02%
Sales Q2Q%-13.59%
Revenue Next Year-5.04%
Revenue Next 2Y4.13%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-326.3%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year147.62%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y32.78%
FCF growth 3Y55.92%
FCF growth 5YN/A
OCF growth 1Y39.3%
OCF growth 3Y40.54%
OCF growth 5YN/A